Latest 10-K annual reports

Grayscale Sui Staking ETF reports a net decrease in assets for 2025 amid SUI price depreciation, while successfully uplisting to NYSE Arca and commencing a redemption program.

Blaize Holdings, Inc. reported a net loss of $206.9 million for 2025, a significant increase from the prior year, raising substantial doubt about its ability to continue as a going concern.

MV Oil Trust reports significant declines in income and distributions as its net profits interest is set to terminate on June 30, 2026, leading to the Trust's dissolution.

VOC Energy Trust reported a significant decrease in net profits interest income and distributable cash for 2025, driven by lower oil prices and reduced sales volumes.

Strategic Storage Trust VI, Inc. reported a net loss of $36.6 million for 2025, driven by ongoing growth and lease-up activities, while maintaining a stable estimated net asset value of $10.00 per share.

Biomea Fusion, a clinical-stage biopharmaceutical company, reported a reduced net loss in 2025 but faces substantial doubt about its ability to continue as a going concern, while strategically focusing on diabetes and obesity treatments.

ECA Marcellus Trust I's 2025 annual report shows a significant increase in distributable income driven by higher natural gas prices, despite a decline in production volumes.

LENZ Therapeutics commercially launched VIZZ, its FDA-approved presbyopia eye drop, in the U.S. in August 2025, generating initial product sales while continuing to incur significant net losses.

VirnetX Holding Corporation reported a net loss of $18.2 million for 2025, despite increased revenue from a DoD subcontract and ongoing development of its cybersecurity platforms.

Comstock Inc. reported a reduced net loss for 2025, driven by significant capital raises and strategic advancements in its solar panel recycling and renewable fuels segments, despite a decline in overall revenue.

Fractyl Health, a clinical-stage metabolic therapeutics company, reported significant net losses and raised substantial doubt about its ability to continue as a going concern, despite advancing its Revita and Rejuva product candidates.

Neurogene Inc. reported a widened net loss for 2025 while making significant clinical and regulatory progress with its lead gene therapy candidate, NGN-401, for Rett syndrome.

GameStop reports a significant increase in net income for fiscal 2025, driven by strategic capital allocation, cost optimization, and growth in collectibles, despite a decline in overall net sales.

Chicago Rivet & Machine Co. reported recurring operating losses and liquidity reduction for fiscal year 2025, raising substantial doubt about its ability to continue as a going concern, despite some revenue growth and efficiency gains.

SCE Recovery Funding LLC and its servicers confirm material compliance with SEC Regulation AB servicing criteria for asset-backed securities for the fiscal year ended December 31, 2025.

Circle Energy, an exploration-stage oil and gas company, reported an increased net loss for 2025 and continues to seek capital to fund its undeveloped Permian Basin acreage.

VenHub Global, Inc. reported a net loss of over $62 million in 2025, a significant increase from the prior year, as it navigates early commercialization and seeks additional capital.

CreditRiskMonitor.com reported a 2% revenue increase to $20.1 million in 2025, but net income declined by 39% to $1.0 million, alongside strategic management changes and continued product development.

Perma-Fix Environmental Services reports modest 2025 revenue growth driven by its Treatment Segment and advances in PFAS destruction technology, despite a net loss and Services Segment decline.

Table Trac, Inc. reported a slight decrease in total revenue for fiscal year 2025, driven by lower system sales, but saw an increase in net income and a significant boost in cash and cash equivalents.

Silver Pegasus Acquisition Corp. (SPAC) files its 2025 annual report, outlining its blank check operations, share structure, and significant risks related to its business combination deadline and potential dilution.

BioAge Labs, Inc. announced positive interim Phase 1 data for its lead program BGE-102, demonstrating significant hsCRP reduction, and confirmed sufficient capital to fund operations through 2029.

Energy Focus, Inc. reported a reduced net loss in 2025, driven by cost controls, but faces ongoing going concern doubts and seeks new capital while expanding into AI data center and energy storage markets.

Leatt Corporation reported a significant financial turnaround in 2025, achieving a net income of $3.26 million on a 41% increase in revenues, compared to a net loss in the prior year.

Hour Loop, an online retailer, reported a 159% increase in net income for 2025, reaching $1.7 million, driven by revenue growth and operational efficiencies despite tariff challenges.

Smithfield Foods, Inc. reported a significant increase in net income from continuing operations for fiscal year 2025, driven by higher sales prices and strategic initiatives, while also announcing a major acquisition and plant construction.

FiscalNote Holdings, Inc. reported a 21% drop in total revenues for 2025, alongside a significant net loss and goodwill impairment, raising concerns about its financial stability and ability to meet debt obligations.

Core & Main, a leading specialty distributor for infrastructure products, reported increased net sales, gross profit, and net income for fiscal year 2025, alongside an expanded share repurchase program.

COMPASS Pathways reports positive Phase 3 results for COMP360 psilocybin in TRD, initiates PTSD trial, and strengthens financial position with recent capital raises.

Achieve Life Sciences' 2025 annual report highlights significant operating losses, ongoing financing needs, and potential FDA approval delays for cytisinicline, despite positive clinical trial results and breakthrough therapy designation.